Toxicity and patient-reported quality of life through 12 months following pelvis-inclusive once-weekly stereotactic body radiotherapy versus conventional IMRT for high-risk prostate cancer: updated results of the SRAM randomized phase II trial

Radiotherapy & Oncology · Elsevier

Аннотация

Publication date: January 2027 Source: Radiotherapy and Oncology, Volume 226 Author(s): Darren MC Poon, Kenneth CW Wong, Daisy CM Lam, Cheuk-Fun Chan, Allen CC Chen, David Johnson, Benjamin HW Lam, Matthew MP Lee, Landon L Chan, Clement CM Chu, CF Ng, Frankie KF Mo, Anthony TC Chan, Tony Mok

Читать у издателя →

Похожие статьи